NasdaqGS:HSICHealthcare
Did Henry Schein’s (HSIC) Expanded vVARDIS Deal Quietly Recast Its Minimally Invasive Dental Strategy?
In early December 2025, Henry Schein, Inc. said it would expand its agreement with Swiss firm vVARDIS to gain exclusive U.S. distribution rights for the drill-free Curodont Repair Fluoride Plus treatment across all dental market segments starting January 1, 2026.
This move deepens Henry Schein’s presence in minimally invasive cavity care, potentially aligning its distribution scale with growing demand for drill- and needle-free dental solutions.
Next, we’ll examine how extending the KKR...